Published in Clin Infect Dis on September 01, 2010
Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis (2013) 3.56
How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa. PLoS One (2012) 1.66
Evaluation of the Whole-Blood Alere Q NAT Point-of-Care RNA Assay for HIV-1 Viral Load Monitoring in a Primary Health Care Setting in Mozambique. J Clin Microbiol (2016) 0.84
Evaluating operational specifications of point-of-care diagnostic tests: a standardized scorecard. PLoS One (2012) 0.78
Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health (2008) 2.36
CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry (2002) 2.25
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol (2002) 1.40
Routine data from prevention of mother-to-child transmission (PMTCT) HIV testing not yet ready for HIV surveillance in Mozambique: a retrospective analysis of matched test results. BMC Infect Dis (2013) 1.23
Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. BMC Infect Dis (2006) 1.15
A quality management systems approach for CD4 testing in resource-poor settings. Am J Clin Pathol (2010) 1.12
Cholera epidemiology in Mozambique using national surveillance data. J Infect Dis (2013) 1.04
Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer. Cytometry (2002) 0.99
Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations. PLoS One (2012) 0.96
Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis (2009) 0.95
Impact of asymptomatic Plasmodium falciparum parasitemia on the imunohematological indices among school children and adolescents in a rural area highly endemic for malaria in southern Mozambique. BMC Infect Dis (2013) 0.89
Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. J Immunol Methods (2011) 0.88
Assessment of measles immunity among infants in Maputo City, Mozambique. BMC Public Health (2008) 0.87
Genetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: implications for integrase inhibitors. AIDS Res Hum Retroviruses (2012) 0.85
Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Transfusion (2009) 0.85
Human leukocyte antigen-A, -B, and -DRB1 allele and haplotype frequencies in the Mozambican population: a blood donor-based population study. Hum Immunol (2010) 0.79
Gene polymorphisms in patients with pulmonary tuberculosis from Mozambique. Mol Biol Rep (2014) 0.78
Evaluating operational specifications of point-of-care diagnostic tests: a standardized scorecard. PLoS One (2012) 0.78
Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, Mozambique. Virol J (2011) 0.76
Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic. PLoS Negl Trop Dis (2011) 0.76
The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations. AIDS (2017) 0.75
Seroepidemiology of Rubella in Mozambique, 2006-2014: Implications for Rubella Immunization in Settings With High Fertility Rates. Pediatr Infect Dis J (2016) 0.75
Nutritional status and its association with physical fitness, physical activity and parasitological indicators in youths from rural Mozambique. Am J Hum Biol (2013) 0.75
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. AIDS (2017) 0.75